|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,502 JPY | +1.49% |
|
+5.55% | -11.54% |
Shin Nippon Biomedical Laboratories, Ltd. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 25,090.9 million compared to JPY 17,748.48 million a year ago. Net income was JPY 6,060.06 million compared to JPY 7,127.63 million a year ago.
Basic earnings per share from continuing operations was JPY 145.56 compared to JPY 171.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.54% | 397M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. 
